Myelomas
A Phase 2, Open-Label, Multicenter Study of BMS-986393, a GPRC5D-directed CAR T Cell Therapy in Adult Participants with Relapsed or Refractory Multiple Myeloma (CA0881000)
- Details
ClinicalTrials.gov ID:
NCT06297226
Diagnosis Type:
NA
USOR Number:
- Address
,
P: